Reckitt Benckiser misled consumers on Nurofen painkillers: Australia court
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Sydney
AN Australian court ordered Reckitt Benckiser on Monday to pull several of its Nurofen pain relief products from the market, saying the British firm had misled consumers by marketing identical products for different types of pain.
The Federal Court ruled that the Nurofen Back Pain, Period Pain, Migraine Pain and Tension Headache products were in fact identical and that Reckitt Benckiser had "engaged in misleading conduct" by labelling them for different ailments.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts